Back
TJX Companies Vs. Novo Nordisk AS Industry Stock Comparison
Sell
50
TJX
TJX Companies
Last Price:
$117.58
Seasonality Move:
5.95%
Sell
25
NVO
Novo Nordisk AS
Last Price:
$78.92
Seasonality Move:
2.91%
Sell
50
TJX Companies (TJX)
is a Sell
Is TJX Companies a Buy, Sell or Hold?
-
The current TJX Companies [TJX] share price is $119.27. The Score for TJX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
TJX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $87.17. The Score for NVO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TJX Stock Price Chart
What is TJX Companies's stock price today?
-
The TJX Companies share price today is $119.27Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TJX is experiencing slight buying pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $87.17Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight selling pressure.
TJX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.6 | Sell |
Relative Strength Index (14 RSI): | 38.13 | Sell |
Chaikin Money Flow: | 1327144 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (122.16 - 125.54) | Sell |
Bollinger Bands (100): | (117.12 - 125.28) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.8 | Buy |
Relative Strength Index (14 RSI): | 50.04 | Buy |
Chaikin Money Flow: | -1341306 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (82.14 - 89.18) | Buy |
Bollinger Bands (100): | (84.56 - 110.62) | Sell |
TJX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 122.67 | Sell |
20-day SMA: | 123.53 | Sell |
50-day SMA: | 122.9 | Sell |
200-day SMA: | 116.61 | Buy |
8-day EMA: | 121.92 | Sell |
20-day EMA: | 122.9 | Sell |
50-day EMA: | 122.8 | Sell |
200-day EMA: | 115.89 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 89.05 | Sell |
20-day SMA: | 86.03 | Buy |
50-day SMA: | 85.25 | Buy |
200-day SMA: | 115.76 | Sell |
8-day EMA: | 88.2 | Sell |
20-day EMA: | 87 | Buy |
50-day EMA: | 89.19 | Sell |
200-day EMA: | 105.41 | Sell |
TJX Companies Earnings Growth & TJX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.24 per share, an increase this year of $0.43 per share, and an increase next year of $0.32 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $0.11 per share, an increase this year of $0.90 per share, and an increase next year of $0.73 per share.
TJX Companies Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |